BRISTOL MYERS SQUIBB CO Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Bristol Myers Squibb Co quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Bristol Myers Squibb Co Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $461M, a 127% increase year-over-year.
  • Bristol Myers Squibb Co Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $367M, a 14% increase year-over-year.
  • Bristol Myers Squibb Co annual Income Tax Expense (Benefit) for 2023 was $400M, a 70.8% decline from 2022.
  • Bristol Myers Squibb Co annual Income Tax Expense (Benefit) for 2022 was $1.37B, a 26.2% increase from 2021.
  • Bristol Myers Squibb Co annual Income Tax Expense (Benefit) for 2021 was $1.08B, a 49% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $367M $461M +$258M +127% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $109M -$398M -$180M -82.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-26
Q1 2024 $289M $392M -$111M -22.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $400M -$88M +$78M +47% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-13
Q3 2023 $322M $203M -$398M -66.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $720M -$218M -$747M -141% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-26
Q1 2023 $1.47B $503M +$99M +24.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $1.37B -$166M +$348M +67.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-13
Q3 2022 $1.02B $601M -$4M -0.66% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $1.02B $529M +$37M +7.52% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $987M $404M -$97M -19.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $1.08B -$514M -$90M -21.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-13
Q3 2021 $1.17B $605M +$226M +59.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 $948M $492M -$1.22B -71.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 $2.16B $501M +$39M +8.44% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $2.12B -$424M -$1.36B -146% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-14
Q3 2020 $3.48B $379M +$396M Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-27
Q2 2020 $3.08B $1.71B +$1.37B +407% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 $1.71B $462M +$198M +75% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $1.52B $931M +$584M +168% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-09
Q3 2019 $931M -$17M -$272M -107% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.2B $337M +$202M +150% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1B $264M -$20M -7.04% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.02B $347M -$2.68B -88.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-10
Q3 2018 $3.7B $255M -$72M -22% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $3.77B $135M -$238M -63.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-25
Q1 2018 $4.01B $284M -$145M -33.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-25
Q4 2017 $4.16B $3.03B +$2.84B +1510% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $1.32B $327M -$17M -4.94% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-25
Q2 2017 $1.33B $373M -$54M -12.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-26
Q1 2017 $1.39B $429M -$20M -4.45% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q4 2016 $1.41B $188M +$410M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-25
Q3 2016 $998M $344M +$87M +33.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $911M $427M +$265M +164% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 $646M $449M +$200M +80.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $446M -$222M -$135M -155% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 $581M $257M -$19M -6.88% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 $600M $162M +$48M +42.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $552M $249M +$200M +408% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 $352M -$87M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-21
Q3 2014 $276M +$150M +119% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 $114M Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-23
Q1 2014 $49M -$2M -3.92% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q3 2013 $126M +$672M Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-24
Q1 2013 -$655M $51M -$494M -90.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 -$161M -$411M -$774M -213% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-13
Q3 2012 $613M -$546M -$1.02B -215% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-23
Q2 2012 $1.63B $251M -$232M -48% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 $1.87B $545M +$145M +36.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 $1.72B $363M -$208M -36.4% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-14
Q3 2011 $1.93B $475M +$163M +52.2% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-24
Q2 2011 $1.77B $483M +$159M +49.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-25
Q1 2011 $1.61B $400M +$49M +14% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 $1.56B $571M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-15
Q3 2010 $312M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 $324M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 $351M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.